140 related articles for article (PubMed ID: 11527738)
1. Utility of boron clusters for drug design. Hansch-fujita hydrophobic parameters pi of dicarba-closo-dodecaboranyl groups.
Yamamoto K; Endo Y
Bioorg Med Chem Lett; 2001 Sep; 11(17):2389-92. PubMed ID: 11527738
[TBL] [Abstract][Full Text] [Related]
2. Utility of boron clusters for drug design. Relation between estrogen receptor binding affinity and hydrophobicity of phenols bearing various types of carboranyl groups.
Endo Y; Yamamoto K; Kagechika H
Bioorg Med Chem Lett; 2003 Nov; 13(22):4089-92. PubMed ID: 14592514
[TBL] [Abstract][Full Text] [Related]
3. Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters.
Endo Y; Iijima T; Yamakoshi Y; Fukasawa H; Miyaura C; Inada M; Kubo A; Itai A
Chem Biol; 2001 Apr; 8(4):341-55. PubMed ID: 11325590
[TBL] [Abstract][Full Text] [Related]
4. Non-natural lipids: Synthesis and characterization of esters from meta-carborane-1-carboxylic acid.
Tribovane DC; Scholz MS
Chem Phys Lipids; 2018 Jan; 210():149-154. PubMed ID: 28865929
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity study of estrogenic agonists bearing dicarba-closo-dodecaborane. Effect of geometry and separation distance of hydroxyl groups at the ends of molecules.
Endo Y; Iijima T; Amakoshi Y; Kubo A; Itai A
Bioorg Med Chem Lett; 1999 Dec; 9(23):3313-8. PubMed ID: 10612591
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and 11C-Radiolabelling of 2-Carboranyl Benzothiazoles.
Gona KB; Thota JL; Baz Z; Gómez-Vallejo V; Llop J
Molecules; 2015 Apr; 20(5):7495-508. PubMed ID: 25915463
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Yoshimi T; Iijima T; Yamakoshi Y
Bioorg Med Chem Lett; 1999 Dec; 9(24):3387-92. PubMed ID: 10617077
[TBL] [Abstract][Full Text] [Related]
8. Dicarba-closo-dodecaboranes as a pharmacophore. Novel potent retinoidal agonists.
Endo Y; Iijima T; Kagechika H; Ohta K; Kawachi E; Shudo K
Chem Pharm Bull (Tokyo); 1999 Apr; 47(4):585-7. PubMed ID: 10319433
[TBL] [Abstract][Full Text] [Related]
9. Dicarba-closo-dodecaboranes as a pharmacophore. Retinoidal antagonists and potential agonists.
Iijima T; Endo Y; Tsuji M; Kawachi E; Kagechika H; Shudo K
Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):398-404. PubMed ID: 10212389
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel androgen receptor antagonists with sterically bulky icosahedral carboranes.
Goto T; Ohta K; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2005 Dec; 13(23):6414-24. PubMed ID: 16099660
[TBL] [Abstract][Full Text] [Related]
11. Potent androgen antagonists based on carborane as a hydrophobic core structure.
Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and DNA-binding properties of dinuclear platinum(II)-amine complexes of 1,7-dicarba-closo-dodecaborane(12).
Woodhouse SL; Rendina LM
Chem Commun (Camb); 2001 Dec; (23):2464-5. PubMed ID: 12240016
[TBL] [Abstract][Full Text] [Related]
13. Boron cluster-based development of potent nonsecosteroidal vitamin D receptor ligands: direct observation of hydrophobic interaction between protein surface and carborane.
Fujii S; Masuno H; Taoda Y; Kano A; Wongmayura A; Nakabayashi M; Ito N; Shimizu M; Kawachi E; Hirano T; Endo Y; Tanatani A; Kagechika H
J Am Chem Soc; 2011 Dec; 133(51):20933-41. PubMed ID: 22066785
[TBL] [Abstract][Full Text] [Related]
14. Insight into lipophilicity of deoxyribonucleoside‑boron cluster conjugates.
Dąbrowska A; Matuszewski M; Zwoliński K; Ignaczak A; Olejniczak AB
Eur J Pharm Sci; 2018 Jan; 111():226-237. PubMed ID: 28986193
[TBL] [Abstract][Full Text] [Related]
15. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
Ma L; Hamdi J; Wong F; Hawthorne MF
Inorg Chem; 2006 Jan; 45(1):278-85. PubMed ID: 16390066
[TBL] [Abstract][Full Text] [Related]
16. Novel iodinated carboranes: synthesis of the 8-iodo-7,9-dicarba-nido-undecaborate anion and 2-iodo-1,7-dicarba-closo-dodecaborane.
Safronov AV; Kabytaev KZ; Jalisatgi SS; Hawthorne MF
Dalton Trans; 2014 Sep; 43(33):12467-9. PubMed ID: 24782077
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and DNA-binding properties of cationic 2,2':6',2' '-terpyridineplatinum(II) complexes containing 1,2- and 1,7-dicarba-closo-dodecaborane(12).
Todd JA; Rendina LM
Inorg Chem; 2002 Jul; 41(13):3331-3. PubMed ID: 12079447
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 3-(12-hydroxy-p-carboranyl)propionic acid, a hydrophobic, N-terminal tyrosine-mimetic for peptides.
Ujváry I; Nachman RJ
Peptides; 2001 Feb; 22(2):287-90. PubMed ID: 11179823
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C modulators bearing dicarba-CLOSO-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Yoshimi T; Kimura K; Itai A
Bioorg Med Chem Lett; 1999 Sep; 9(17):2561-4. PubMed ID: 10498208
[TBL] [Abstract][Full Text] [Related]
20. 1,2-Dicarba-closo-dodecaboran-1-yl naphthalene derivatives.
Ohta K; Goto T; Endo Y
Inorg Chem; 2005 Nov; 44(23):8569-73. PubMed ID: 16270997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
